Schizophrenia News and Research

Latest Schizophrenia News and Research

Novel neurotransmitter could fight against neurological diseases

A team of scientists has discovered that D-aspartic acid is a novel neurotransmitter that could potentially be used in the fight against neurological diseases such as Parkinson's and schizophrenia.

6 May 2011

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

The House is slated Thursday to take up a conference committee report on a bill designed to put the state on the path to universal health care by 2017 if not sooner. The bill sets up a new Green Mountain Care Board to design a system to provide health insurance to every Vermont resident.

6 May 2011

Insights into psychiatric disorders

Social deficits are common in several psychiatric disorders, including autism spectrum disorders and schizophrenia. Individuals with severe social dysfunction can experience significant difficulties with everyday functioning.

5 May 2011

Brain function variations may increase person's risk of drug abuse

One can look at drug addiction as a moral issue, a social ill, or a criminal problem. But Lynn Oswald's experience studying the neuroscience of addiction tells her that it is something else entirely: a disease of the brain.

30 Apr 2011

CTSN focuses on new prairie vole model for autism treatment

Researchers at the Center for Translational Social Neuroscience at Emory University are focusing on prairie voles as a new model to screen the effectiveness of drugs to treat autism.

29 Apr 2011

Drug subsidy issues out of PBS’ hands - almost

According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.

29 Apr 2011

Researchers confirm fish livers as good source of fatty acids

The fishing industry usually discards fish livers, but a team of researchers from the University of Almeria has confirmed that they are a good source of polyunsaturated fatty acids, which are beneficial to health. Anchovies are one of the fish whose livers contain the highest levels of these substances.

29 Apr 2011

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Shire plc, the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) Capsules assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.

28 Apr 2011

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.

28 Apr 2011

Biologists determine molecular structure of GluN2D receptor subunit

Structural biologists at Cold Spring Harbor Laboratory in collaboration with colleagues at Emory University have determined the molecular structure of a key portion, or subunit, of a receptor type commonly expressed in brain cells.

27 Apr 2011

Viewpoints: Shortsighted fight against fund to prevent disease; strengthening regulators' control of premium increases

House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.

27 Apr 2011

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

Cortex Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent that protects its lead AMPAKINE® molecule, CX1739.

26 Apr 2011

Curemark CM-182 demonstrates positive results for schizophrenia in transgenic chakragati model of psychosis

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic chakragati (ckr) model of psychosis. The mouse model screening was performed by the Contract Research Organization, Cerca Insights.

25 Apr 2011

New findings can lead to better understanding of neurological development, cancer metastasis

By shedding new light on how cells migrate in the developing brain, researchers at Fred Hutchinson Cancer Research Center also may have found a new mechanism by which other types of cells, including cancer cells, travel within the body.

25 Apr 2011

State news: Calif. report faults screening of in-home care providers

Two of the state's largest private medical practices are in talks to merge into a giant doctor-run group that would care for nearly a million Massachusetts patients and significantly escalate the pace of health care consolidation throughout the state. Atrius Health, which runs the Harvard Vanguard system and four other doctors practices, is in advanced talks with Fallon Clinic, the Worcester-based medical group.

22 Apr 2011

Veterans with mental illness show increased rates of substance use disorders

A new study published in The American Journal on Addictions reveals that Veterans who suffer from mental health disorders also have high rates of substance use disorders.

21 Apr 2011

Neuralstem signs MoU with BaYi Brain Hospital for ischemic stroke program in China

Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China.

21 Apr 2011

America’s best loved drugs: Report

According to the latest report from consulting firm IMS Health, Americans are consuming a lot of prescription drugs. And they seem especially fond of those to lower their cholesterol, relieve heartburn, aid in depressive disorders and lessen pain. Overall, however, their spending on such drugs is slowing.

20 Apr 2011

RCSI conducts study to examine psychiatric disorders in people with epilepsy

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital, Dublin, have conducted the first study of its kind to examine in detail, the basis of psychiatric disorders which occur in people with epilepsy.

20 Apr 2011